About Astellas Pharma
Astellas Pharma is a company based in Chiba (Japan) founded in 1923.. The company has 37 employees as of April 01, 2024. Astellas Pharma has completed 15 acquisitions, including Agensys, AudentesTherapeutics and Ganymed Pharmaceuticals.
- Headquarter Chiba, Japan
- Employees 37 as on 01 Apr, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Astellas Pharma India Private Limited
- Date of Incorporation 14 Nov, 2008
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$3.67 M (USD)-31.32as on Mar 31, 2023
-
Net Profit
$103.97 K (USD)-79.82as on Mar 31, 2023
-
EBITDA
$102.18 K (USD)-85.17as on Mar 31, 2023
-
Latest Funding Round
- Investors
-
Employee Count
37
as on Apr 01, 2024
-
Investments & Acquisitions
Agensys
& 14 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
91 people
Software Development Team
63 people
Sales and Marketing
27 people
Operations Team
25 people
Product Management Team
24 people
Human Resources and Administration
19 people
Head Team
19 people
Senior Team
18 people
Unlock access to complete
Funding Insights of Astellas Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Grant - Astellas Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Astellas Pharma
Astellas Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Institute on Drug Abuse. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Scientific research on drug use and addiction is supported.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Astellas Pharma
Astellas Pharma has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include Agensys, AudentesTherapeutics and Ganymed Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for cancer and arthritis are developed through API repositioning.
|
2020 | ||||
|
Convertible CAR-T cell technology for cancer treatment is developed.
|
2017 | ||||
|
Developer of neurodiagnostic techniques
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Astellas Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Astellas Pharma Comparisons
Competitors of Astellas Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Astellas Pharma
Frequently Asked Questions about Astellas Pharma
When was Astellas Pharma founded?
Astellas Pharma was founded in 1923 and raised its 1st funding round 97 years after it was founded.
Where is Astellas Pharma located?
Astellas Pharma is headquartered in Chiba, Japan. It is registered at Chiba, Chiba, Japan.
Who is the current CEO of Astellas Pharma?
Naoki Okamura is the current CEO of Astellas Pharma.
How many employees does Astellas Pharma have?
As of Apr 01, 2024, the latest employee count at Astellas Pharma is 37.
What is the annual revenue of Astellas Pharma?
Annual revenue of Astellas Pharma is $3.67M as on Mar 31, 2023.
What does Astellas Pharma do?
Astellas Pharma was founded in 1923 and is headquartered in Chiba, Japan. Operations center on the pharmaceutical sector, with emphasis placed on generic medicines. Development, production, and distribution occur for markets in Japan, North America, Europe, and Asia. Annual revenues reached 11.21 billion in 2022, alongside a net profit of 0.73 billion. Leadership is provided by CEO Naoki Okamura.
How many acquisitions has Astellas Pharma made?
Astellas Pharma has made 15 acquisitions, including Agensys, AudentesTherapeutics, and Ganymed Pharmaceuticals.
Who are Astellas Pharma's investors?
Astellas Pharma has 1 investor. Key investors include National Institute on Drug Abuse.